Adipotsity kostnogo mozga yavlyayutsya ingibitorami gemopoeticheskogo mikrookruzheniya

References

[1] Askmyr М., Sims N., Martin J., Purton L. What is the true nature of the osteoblastic hematopoietic stem cell niche? Trends Endocrinol. Metab., on-line publ. 13 July 2009.

[2] Moitra J., Mason M., Olive M. et al. Life without white fat: a transgenic mouse. Genes Dev. 1ЭЭ8; 12(20): 3168-81.

[3] Yang L, Bryder D., Adolfsson J. et al. Identification of LinC-)Sca1 [ + )kit[ + )CD34( + )Flt3- short-term hematopoietic stem cells capable of rapidly reconstituting and rescuing myeloablated transplant recipients. Blood 2005; 105(7): 2717-23.

[4] Calvi L., Adams G., Weibrecht K. et al. Osteoblastic cells regulate the haematopoietic stem cell niche. Nature 2003; 425(6960): 841-6.

[5] Zhang J., Niu C, Ye L. et al. Identification of the haematopoietic stem cell niche and control of the niche size. Nature 2003; 425(6960): 836-41.

[6] Tavassoli M., Maniatis A., Crosby W. Induction of sustained hemopoiesis in fatty marrow. Blood 1974; 43(1): 33-8.

[7] Botolin S., McCabe L. Inhibition of PPARgamma prevents type I diabetic bone marrow adiposity but not bone loss. J. Cell Physiol. 2006; 209(3): 967-76.

[8] Furuhashi M., Tuncman G., йдгдьп С. et al. Treatment of diabetes and atherosclerosis by inhibiting fatty-acid-binding protein aP2. Nature 2007; 447(7147): 959-65.

RIGHTS & PERMISSIONS

Eco-Vector